公司資料
Shockwave Medical 股價、新聞與催化劑
- 股票代碼:
- SWAV
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for SWAV.
公司概覽
業務概覽
Shockwave Medical was a medical technology company focused on intravascular lithotripsy for cardiovascular disease before being acquired by Johnson & Johnson. Its platform changed how clinicians approached calcium-related vessel treatment.
所在地與產業分類
Shockwave was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in high-growth cardiovascular medtech rather than biotech.
商業模式特徵
The company generated value through procedure adoption, product expansion, and the widening use of its lithotripsy platform. Investors watched procedural growth, international adoption, and system penetration.
生技產業定位
Shockwave was outside biotech but was one of the most important procedure-driven medtech growth names. Because it has been acquired, it is now a historical reference point rather than a live public company.
未來催化劑
- Shockwave’s catalyst story is still intravascular lithotripsy adoption and how the franchise is being integrated into the broader commercial footprint. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。